Collapse all
The Business Model Canvas reveals a shift from a simple clinical calculator to a critical adherence-management system. The venture's viability depends on integrating into existing psychiatric workflows to mitigate the high risk of non-adherence inherent in severe mental health populations.
4 Academic Research Institutions Partnerships with neurobiology and psychiatry departments to keep the 'dosage' guidelines updated with the latest RCT data. Electronic Health Record (EHR) Providers Integration partners like Epic or Cerner to allow psychiatrists to embed prescriptions directly into patient charts. Public Health Systems (e.g., NHS) Strategic partners for large-scale clinical validation and systemic adoption across primary and secondary care. Fitness Tracking Platforms API integrations with wearable data (Apple Health, Fitbit) to provide clinicians with objective adherence metrics. 4 Evidence Synthesis Translating complex meta-analyses into actionable, diagnosis-specific exercise prescriptions (intensity, duration, frequency). Adherence Framework Design Developing behavioral change modules specifically tailored to the cognitive barriers found in schizophrenia and ADHD. Clinical Workflow Integration Designing the UI/UX to ensure the tool adds minimal friction to a psychiatrist's already burdened consultation time. Outcome Monitoring Tracking the correlation between exercise adherence and medication stability to prove clinical efficacy. 3 Proprietary Dosage Database A structured library of evidence-based activity regimens mapped to specific psychiatric diagnoses. Behavioral Science Expertise Specialists in psychiatric adherence to build the support system that prevents patient dropout. Clinical Validation Data Pilot study results demonstrating reduced hospitalization rates through integrated exercise prescriptions. 3 Precision Prescribing Replaces vague 'be active' advice with specific, evidence-based dosages tailored to ADHD, depression, and schizophrenia. Risk Mitigation Reduces the risk of hospitalization by utilizing an adherence framework that addresses the systemic instability of psychiatric patients. Clinical Decision Support Empowers psychiatrists to offer a holistic, adjunctive treatment plan without needing to be exercise physiology experts. 3 B2B Clinical Partnership High-touch relationship management with hospital administrators and lead psychiatrists to ensure tool adoption. Clinician Feedback Loop Iterative co-development with users (psychiatrists) to refine the adherence tracking interface. Patient-Centric Support Indirect relationship via the clinician, focusing on patient empowerment and education to overcome adherence barriers. 3 EHR App Marketplaces Distribution through integrated health software stores used by clinics and hospitals. Medical Conferences Direct outreach at psychiatry and mental health summits to demonstrate the tool to key opinion leaders. Health System Procurement Direct B2B sales to large healthcare networks like the Mayo Clinic or NHS trusts. 3 Psychiatrists Medical professionals seeking evidence-based ways to improve patient stability and reduce medication reliance. Large Health Systems Organizations like Mayo Clinic focused on reducing readmission rates and improving overall patient outcomes. Public Health Authorities Government bodies (e.g., NHS) aiming to lower the systemic cost of mental health crises through preventative lifestyle interventions. 3 R&D and Evidence Mapping Ongoing costs for medical researchers to synthesize new RCTs and update prescription guidelines. Software Development Costs associated with building secure, HIPAA/GDPR compliant infrastructure and EHR integrations. Clinical Validation Trials Expenses related to running pilot studies to prove the link between the tool and reduced hospitalization. 3 Annual SaaS Licensing Per-clinician or per-department annual subscription fees paid by hospitals or private practices. Enterprise Implementation Fee One-time setup and integration fee for large-scale deployments within health systems (e.g., NHS). Value-Based Reimbursement Potential performance-based bonuses tied to the reduction of patient hospitalization rates. The idea identifies specific high-value beneficiaries like the NHS and Mayo Clinic, making it appropriate to map out the value proposition and delivery channels. · Generated 2026-10-01 by cavi/gemma4-31b-it-awq-4bit-32kAI-generated